Vergoeding 2015-2019 voor ATC-subgroep A10AB : Snelwerkende insulines voor injectie
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| A10AB01 Insuline (humaan) (Insuman rapid ®) | 718.630 | 660.680 | 558.020 | 486.270 | 433.700 |
| A10AB04 Insuline lispro (Humalog ®) | 6.607.800 | 7.020.300 | 7.076.600 | 6.859.600 | 6.620.100 |
| A10AB05 Insuline aspart (Novorapid ®) | 44.177.100 | 44.728.100 | 45.342.600 | 44.935.000 | 44.882.400 |
| A10AB06 Insuline glulisine (Apidra ®) | 3.729.400 | 3.883.500 | 3.840.100 | 3.669.400 | 3.418.100 |
| Totaal | 55.232.930 | 56.292.580 | 56.817.320 | 55.950.270 | 55.354.300 |